Friday, May 27, 2022 5:07:09 PM
The facts are clear at this point. They rely on just 3 customers for the majority of their revenues. It appears they lost HP, and there is no news that Car Parts will be renewed. They pay Great Eagle, Frangipani, and Briones (the 3 Directors) over $750,000 annually while the business can't turn a $2 million profit.
The company is a dilution machine that gifted 525m out of 687m public shares to company insiders, consultants, and "lenders" for zero money to the company. Public shareholders have been screwed.
Worse, there are 9.2 billion more shares waiting to be converted for zero money to the company. For reputable companies, the business gets real money for issuing new shares. Not UNQL. Their insiders and lenders get to convert for free.
Current market cap is $9 million which is appropriate for a company purchased for $8 million 2 years ago that still has 1% margins. Not only does the general market have UNQL pegged, there is virtually no public interest to actually buy any shares. Smart investors know impending dilution doom when they see it.
So, to the delight of the pure hatred posted here, this voice is leaving for good. Nothing more needs to be said about the utter failure that is UNQL stock. Down 90% and only going lower over time. RIP
Recent UNQL News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 09:23:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 12:55:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:30:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 01/17/2024 09:23:29 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/31/2023 09:28:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 10:18:01 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/15/2023 10:02:56 AM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 08/30/2023 02:13:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2023 09:00:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM